Navigation Links
Corgenix to Host Conference Call to Discuss Second Quarter Results
Date:2/2/2009

DENVER, Feb. 2 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, February 12, 2009, at 4:00 PM EST to discuss the Company's financial and operating performance for its second fiscal quarter ended December 31, 2008, and the status of the Company's product development and marketing activities.

Corgenix invites all those interested in hearing management's discussion of the annual results to join the call by dialing:

US attendees: (800) 862-9098

International attendees: +1 785 424 1051

Conference code is: CORGENIX

A question-and-answer session will follow the presentation by Corgenix management.

A replay will be available for 30 days following the call by dialing (800) 723-5782 for US participants and +1 402 220 2663 for international participants.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 52 diagnostic products through a global distribution network. More information is available at www.corgenix.com.


'/>"/>
SOURCE Corgenix Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Corgenix Signs Collaboration With Battelle
2. Corgenix Receives Two Additional Patents on AtherOx(R) Technology
3. Corgenix to Host Conference Call to Discuss First Quarter Results
4. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
5. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
6. Corgenix Reports Fiscal 2008 Financial Results
7. Corgenix to Host Conference Call to Discuss Fiscal 2008 Results
8. Corgenix Expands Scientific Advisory Board
9. Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco
10. Corgenix to Host Conference Call to Discuss Third Quarter Fiscal 2008 Results
11. Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... 2017 , ... Baltimore biotech firm, PathSensors, announced that its ... developing and issuing recommendations to grow Maryland's biohealth industry and position the state ... , The recommendations are contained in a report from the Maryland ...
(Date:5/19/2017)... ... ... In response to the strong base of evidence supporting the use of ... of their Gait Trainer 3 with an Integrated Music Therapy option. This is the ... rehabilitating individuals with cerebral palsy, traumatic brain injury, stroke and Parkinson’s disease. , ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great ... company continues to grow. CSM has doubled in size over the past six ... aggressive growth strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger ...
(Date:5/18/2017)... ... May 17, 2017 , ... USDM Life ... for the life sciences and healthcare industries, is honored that Jay Crowley ... Devices conference in Brussels, Belgium. , Crowley played a crucial role in the ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):